Stock Events

Stock Events

Seres Therapeutics (MCRB) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.5

-0.41

-0.31

-0.22

Details

Expected EPS

-0.274083

Actual EPS

-0.22

Surprise EPS

0.05

Surprise Percent

+19.73%

Description

Seres Therapeutics (MCRB) has reported earnings of -0.22 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.